期刊文献+

肝硬化患者血IL-1β、TNF-α及尿crosslaps水平与骨密度关系 被引量:1

The Relationship Between Serums Levels of IL-1β,TNF-α,Urine Crosslaps and Bone Mineral Density of Liver Cirrhosis Patients
下载PDF
导出
摘要 目的探讨血清IL-1β、TNF-α及尿Crosslaps变化对肝硬化患者骨密度变化的影响。方法测定46例肝硬化患者血清IL-1β、TNF-α及尿Crosslaps水平及骨密度,并与25例健康者对照。结果 :肝硬化组血清IL-1β、TNF-α及尿Crosslaps水平显著升高(P<0.05),骨质疏松组(OP)较非骨质疏松(NOP)升高更显著(P<0.05),OP组IL-1β、TNF-α及尿Crosslaps水平与骨密度呈负相关。结论 IL-1β、TNF-α及尿Crosslaps水平升高导致骨吸收增强,参与了肝性骨病的发生,降低体内IL-1β、TNF-α及尿Crosslaps水平对HBD防治有一定作用。 Objective To investigate the relationship between serums levels of IL-1β,TNF-α,urine crosslaps and bone mineral density of liver cirrhosis patients.Methods Levels of IL-1β,TNF-α,urine crosslaps were detected in 46 liver cirrhosis patients and 25 age-matched healthy controls.Results The levels of IL-1β,TNF-α,urine crosslaps in liver cirrhosis patients increased more than that of controls(P〈0.05),osteoporosis(OP) group's much higher than non-osteoporosis(NOP) group's.we also found the levels of IL-1β,TNF-α,urine crosslaps in OP group's had negative correlation with mean bone density.Conclusion The elevation of serum IL-1β、TNF-α and urine crosslaps can accelerate bone resorption and lead to hepatic bone disease(HBD).Reducing the concentration and blocking the effect of serum IL-1β,TNF-α and urine crosslaps may be very important for prevention and treatment of HBD.
出处 《中国医药指南》 2011年第17期200-201,共2页 Guide of China Medicine
关键词 肝硬化 骨密度 Liver cirrhosis Bone mineral density
  • 相关文献

参考文献7

  • 1刘倩,毛海婷,王文奇,王义国,陈自平,闫明先.慢性肝病患者血清VitD_3水平与骨代谢的关系[J].中国骨质疏松杂志,2001,7(4):328-329. 被引量:6
  • 2Porsch M.Evaluation of serum levels of the inflamm troy cytokines IL-6 and IL-8hepatocirhosis[J].Hepatograstroenterol,2001,34(7):568.
  • 3郭世.骨质疏松基础与临床[M].天津:天津科学技术出版社,2001:135-142.
  • 4Horowit Z.Cytokines and estrogen in bone:Antiosteoporotic effects[J].Science,1993,260(5108):626-627.
  • 5Gur A,Denli A,Nas K,et al.Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy[J].Rheumatol Int,2002,22(2):194-198.
  • 6Burgess T,Qian Y,Kaufman S,et al.The ligand forosteoprotegerin (OPGL) directly activates mature osteoclasts[J].Cell Biol,1999,145(3):527-538.
  • 7Bonde M,Qvist P,Fledelius C,etal.Immunoassay for quantifying typy I collagen degradation products in ruine evaluated[J].Clin Chem,1994,40(11):2022-2025.

二级参考文献3

共引文献6

同被引文献7

  • 1Kootala S,Ossipov D,van den Beucken JJ,et al.Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treament for osteoporosis[J].Biomater Sci,2015;3(8):1197-207.
  • 2Mumm JB,Emmerich J,Zhang X,et al.IL-10 elicits IFNγ-dependen tumor immune surveillance[J].Cancer Cell,2011;20(6):781-96.
  • 3Franz M,Doll F,Grun K,et al.Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain a of fibronectin[J].Int J Cardiol,2015;195:311-22.
  • 4Geissler K,Jager E,Ohler L,et al.Interleukin-10 inhibits autonomous myelopoiesis in patients with myelofibrosis[J].Eur J Haematol,2015;95(3):239-43.
  • 5Lems WF,Saag K.Bisphosphonates and glucocorticoid-induced osteoporosis:cons[J].Endocrine,2015;49(3):628-34.
  • 6Sahni S,Mangano KM,Mc Lean RR,et al.Dietary approaches for bone health:lessons from the Framingham Osteoporosis Study[J].Curr Osteoporos Rep,2015;13(4):245-55.
  • 7Warriner AH,Outman RC,Allison JJ,et al.An internet-based controlled trial aimed to improve osteopososis prevention among chronic glucocorticoid users[J].J Rheumatol,2015;42(8):1478-83.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部